Success Stories: From Molecules to Medicine: NAILG Helps Researcher Secure NIW Approval for Advancing Glioblastoma Treatment in Older Adults

Client’s Testimonial:

“I love Chen immigration attorneys. My friends recommended this firm to me, and I have told them I have never regretted using them. I love the way they prepared my petition. The person is familiar and current in my field. I will surely recommend the firm to others.”

On October 31^st, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Research Assistant III in the field of Molecular Biology (Approval Notice).

General Field: Molecular Biology

Position at the Time of Case Filing: Research Assistant III

Country of Origin: Nigeria

State of Residence at the Time of Filing: Illinois

Approval Notice Date: October 31^st, 2025

Processing Time: 11 months, 17 days (Premium Processing Upgrade Requested)

Case Summary:

An accomplished molecular biologist achieved approval of her EB-2 NIW (National Interest Waiver) petition with the assistance of North America Immigration Law Group (NAILG). Her research centers on developing novel treatment strategies for glioblastoma in older adults with diabetes, focusing on the insulin pathway and drug interactions to improve therapeutic outcomes and enhance patient survival. This line of work carries clear, substantial merit and national importance, as it addresses an urgent medical challenge within an aging U.S. population increasingly affected by both diabetes and cancer.

At the time of filing, the petitioner held a Ph.D., M.S., and B.S. in Anatomy and was working as a research scientist focusing on the molecular mechanisms underlying neurological diseases. Her ongoing work, supported by funding from the National Institutes of Health (NIH), integrates molecular biology, biochemistry, and pathology to identify therapeutic targets and develop interventions for glioblastoma, a notoriously aggressive brain cancer with limited treatment options for diabetic and elderly patients.

Her research achievements are reflected in her extensive publication record, which includes 15 peer-reviewed journal articles (3 first-authored and 1 co-first-authored) that have collectively been cited 31 times by independent researchers. Her studies have illuminated critical biological pathways linking metabolic factors—such as dietary sugars—to neurological disorders, establishing her as a respected contributor to cancer and metabolic disease research.

As highlighted by an independent expert:

“By shedding light on how fructose impacts brain inflammation and glial cell formation, [Client] has elucidated the impact of nutrition on brain health and provided valuable insights for treating various other brain conditions, including brain cancers such as glioblastoma. Her contributions enhance therapeutic efficacy, reduce mortality rates, and alleviate the emotional and financial burden on families.”

This recognition underscores both the scientific and humanitarian value of her work, bridging fundamental research and clinical relevance.

With NAILG’s guidance and well-documented evidence of her scientific excellence, her NIW petition was successfully approved. This outcome affirms both the petitioner’s pivotal role in advancing therapeutic strategies for high-risk populations and NAILG’s ongoing commitment to supporting researchers whose work contributes meaningfully to U.S. public health and medical innovation.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Ten Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With more than 58,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to over 58,000 in 2025.